1.
2.
Article
Dans Anglais
| IMSEAR
| ID: sea-64955
Résumé
Intravesical bacillus Calmette-Guerin (BCG) is used in patients with urinary bladder carcinoma. Although it is generally well tolerated, granulomatous hepatitis is a rare but serious complication. We report a 42-year-old man and a 56-year-old man who developed granulomatous hepatitis following intravesical BCG. One of them was treated successfully with antitubercular therapy; the other died because of BCG sepsis and multi-organ failure.
Sujets)
Administration par voie vésicale , Adulte , Antituberculeux/usage thérapeutique , Vaccin BCG/effets indésirables , Ponction-biopsie à l'aiguille , Carcinome transitionnel/traitement médicamenteux , Issue fatale , Humains , Foie/microbiologie , Mâle , Adulte d'âge moyen , Tuberculose hépatique/traitement médicamenteux , Tumeurs de la vessie urinaire/traitement médicamenteux
3.
Article
Dans Anglais
| IMSEAR
| ID: sea-65171